BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 9538022)

  • 1. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
    Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
    Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of prothrombinase activity by protein S.
    van 't Veer C; Butenas S; Golden NJ; Mann KG
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cell generation of thrombin via functional prothrombinase assembly.
    VanDeWater L; Tracy PB; Aronson D; Mann KG; Dvorak HF
    Cancer Res; 1985 Nov; 45(11 Pt 1):5521-5. PubMed ID: 4053025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a homozygous Gly11Val mutation in the Gla domain of coagulation factor X.
    Chafa O; Tagzirt M; Tapon-Bretaudière J; Reghis A; Fischer AM; LeBonniec BF
    Thromb Res; 2009 May; 124(1):144-8. PubMed ID: 19135706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
    Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
    Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly and regulation of prothrombinase complex on B16F10 melanoma cells.
    Kirszberg C; Rumjanek VM; Monteiro RQ
    Thromb Res; 2005; 115(1-2):123-9. PubMed ID: 15567463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation.
    Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Roberts HR
    Thromb Haemost; 1998 Oct; 80(4):578-84. PubMed ID: 9798973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-crystal structure and inhibition of factor Xa by PD0313052 identifies structurally stabilized active site residues of factor Xa and prothrombinase.
    Gould WR; Cladera E; Harris MS; Zhang E; Narasimhan L; Thorn JM; Leadley RJ
    Biochemistry; 2005 Jul; 44(26):9280-9. PubMed ID: 15981994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin.
    Scandura JM; Ahmad SS; Walsh PN
    Biochemistry; 1996 Jul; 35(27):8890-902. PubMed ID: 8688425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, purification, and characterization of recombinant human factor X.
    Rudolph AE; Mullane MP; Porche-Sorbet R; Miletich JP
    Protein Expr Purif; 1997 Aug; 10(3):373-8. PubMed ID: 9268685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.
    Betz A; Vlasuk GP; Bergum PW; Krishnaswamy S
    Biochemistry; 1997 Jan; 36(1):181-91. PubMed ID: 8993332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trp2063 and Trp2064 in the factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complex.
    Peng W; Quinn-Allen MA; Kim SW; Alexander KA; Kane WH
    Biochemistry; 2004 Apr; 43(14):4385-93. PubMed ID: 15065883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional mapping of charged residues of the 82-116 sequence in factor Xa: evidence that lysine 96 is a factor Va independent recognition site for prothrombin in the prothrombinase complex.
    Manithody C; Rezaie AR
    Biochemistry; 2005 Aug; 44(30):10063-70. PubMed ID: 16042383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation.
    Bouchard BA; Catcher CS; Thrash BR; Adida C; Tracy PB
    J Biol Chem; 1997 Apr; 272(14):9244-51. PubMed ID: 9083058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.
    Hackeng TM; van 't Veer C; Meijers JC; Bouma BN
    J Biol Chem; 1994 Aug; 269(33):21051-8. PubMed ID: 8063724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosites determine macromolecular substrate recognition by prothrombinase.
    Krishnaswamy S; Betz A
    Biochemistry; 1997 Oct; 36(40):12080-6. PubMed ID: 9315846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet prothrombinase in health and disease.
    Crook M
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):167-74. PubMed ID: 2130928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.